CLVT logo

CLARIVATE PLC

CLVTNYSE
๐Ÿ† #1870 by market capEarnings Nov 4US Equity
$1.91โ–ฒ $0.02 (+1.06%)
๐ŸŒ™ After hours$1.91โ–ฒ 0.00%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ฒ 1.1%
7dโ–ผ 1.5%
14dโ–ผ 11.0%
30dโ–ผ 16.6%
1yโ–ผ 52.6%
๐ŸฆMarket Cap
$1.22B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-3.5%
Declining
๐Ÿ“ŠGross Margin
66.8%
High
๐Ÿ’ตFCF Margin
13.6%
Healthy
โš–๏ธP/S Ratio
0.5x
Cheap
Otter Score
54
Weak

Trading Snapshot

Day Range
$1.90 โ€“ $1.94
52-Week Range
$1.66 โ€“ $4.56
Volume
$2.55B
Avg Volume
$2.99B
Shares Outstanding
639.7M
Next Earnings
Sep 26, 2026

Fundamentals Snapshot

Annual Revenue
$2.46B
Last Q Revenue
$587M
P/E Ratio
โ€”
P/S Ratio
0.5x
EPS (TTM)
$-0.52
Dividend Yield
0.00%

Why Investors Own CLVT

  • โœ“High-growth profile โ€” revenue up +24.2% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 25% gross margin and 18% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$2.46Bโ–ฒ +22.1% YoY
Gross Margin (TTM)
25.1%โ–ฒ +2.8% YoY
Operating Income (TTM)
$518Mโ–ฒ +22.1% YoY
Free Cash Flow (TTM)
$435Mโ–ฒ +22.1% YoY

About CLARIVATE PLC

Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
54/100

Analyst Ratings

โ“˜
Consensus
Hold
12 analysts
Strong Buy1
Buy0
Hold7
Sell2
Strong Sell2
Ratings as of Aug 2026

Latest News & Updates